IL2 and breast cancer: Similarly, our findings suggest that increased randomness in the patterns of expression of the IL2 pathway, a well-known tumour suppressor pathway mediating tumour inhibition through formation of natural killer cells [34], is a critical determinant of breast cancer metastasis.